Virtu Financial’s Edwards Lifesciences EW Stock Holding History

Virtu Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-48,084	Closed	-$3.17M	–	1690
2024 Q3	$3.17M	Buy	+48,084	New	+$3.49M	0.17%	83
2023 Q4	–	Sell	-12,849	Closed	-$890K	–	1684
2023 Q3	$890K	Buy	+12,849	New	+$1.03M	0.09%	201
2023 Q1	–	Sell	-3,861	Closed	-$288K	–	1671
2022 Q4	$288K	Sell	3,861 -19,558	-84%	-$1.51M	0.04%	511
2022 Q3	$1.94M	Buy	+23,419	New	+$2.25M	0.18%	95
2022 Q1	–	Sell	-10,188	Closed	-$1.32M	–	1649
2021 Q4	$1.32M	Buy	10,188 +7,776	+322%	+$907K	0.14%	143
2021 Q3	$273K	Buy	+2,412	New	+$275K	0.02%	762
2019 Q4	$1.19M	Buy	+15,354	New	+$1.2M	0.12%	191
2019 Q3	–	Sell	-48,888	Closed	-$3.01M	–	1516
2019 Q2	$3.01M	Buy	48,888 +44,253	+955%	+$2.68M	0.18%	78
2019 Q1	$296K	Buy	+4,635	New	+$265K	0.02%	800
2018 Q3	–	Sell	-32,217	Closed	-$1.56M	–	1716
2018 Q2	$1.56M	Buy	+32,217	New	+$1.5M	0.09%	234
2017 Q4	–	Sell	-15,609	Closed	-$569K	–	2510
2017 Q3	$569K	Buy	+15,609	New	+$595K	0.03%	814

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Virtu Financial's EW Position: Q4 2024 in Review

Virtu Financial sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 48,084 shares — an estimated $3.17M sold.

Virtu Financial first reported a position in EW in Q3 2017 and held it in 11 quarters. The position peaked at $3.17M in Q3 2024. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2024.

Virtu Financial reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
Virtu Financial sold 48,084 Edwards Lifesciences shares in Q4 2024, an estimated $3.17M.
Virtu Financial first reported a position in Edwards Lifesciences in Q3 2017 and held it in 11 quarters.
Virtu Financial's Edwards Lifesciences position peaked at $3.17M in Q3 2024.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.